Results-Based Financing Impact Evaluation 2015
Health Facility Endline Survey
Cameroon, 2015
Get Microdata
Reference ID
CMR_2015_RBFIE-FEL_v01_M
Producer(s)
Damien de Walque
Created on
Jan 30, 2025
Last modified
Jan 30, 2025
Page views
20439
Downloads
14
[14.1619] Quelle est la quantité de [Fansidar / Sulphadoxine-Pyrimethamine (SP) (f1_14_1619)
Data file: f1_principal.dta
Overview
Valid:
226
Invalid:
7
Minimum:
0
Maximum:
5000
Type:
Discrete
Decimal:
0
Start:
6052
End:
6055
Width:
4
Range:
0 - 5000
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 14 |
6.2%
|
|
| 12 | 1 |
0.4%
|
|
| 16 | 1 |
0.4%
|
|
| 20 | 3 |
1.3%
|
|
| 24 | 1 |
0.4%
|
|
| 30 | 1 |
0.4%
|
|
| 40 | 1 |
0.4%
|
|
| 50 | 5 |
2.2%
|
|
| 60 | 1 |
0.4%
|
|
| 75 | 2 |
0.9%
|
|
| 80 | 3 |
1.3%
|
|
| 89 | 1 |
0.4%
|
|
| 90 | 1 |
0.4%
|
|
| 95 | 11 |
4.9%
|
|
| 100 | 7 |
3.1%
|
|
| 120 | 1 |
0.4%
|
|
| 125 | 1 |
0.4%
|
|
| 128 | 1 |
0.4%
|
|
| 129 | 1 |
0.4%
|
|
| 130 | 2 |
0.9%
|
|
| 140 | 1 |
0.4%
|
|
| 141 | 2 |
0.9%
|
|
| 150 | 4 |
1.8%
|
|
| 160 | 1 |
0.4%
|
|
| 174 | 1 |
0.4%
|
|
| 200 | 10 |
4.4%
|
|
| 215 | 1 |
0.4%
|
|
| 246 | 1 |
0.4%
|
|
| 300 | 7 |
3.1%
|
|
| 330 | 1 |
0.4%
|
|
| 400 | 1 |
0.4%
|
|
| 480 | 1 |
0.4%
|
|
| 482 | 1 |
0.4%
|
|
| 500 | 78 |
34.5%
|
|
| 502 | 1 |
0.4%
|
|
| 525 | 6 |
2.7%
|
|
| 568 | 1 |
0.4%
|
|
| 600 | 1 |
0.4%
|
|
| 603 | 1 |
0.4%
|
|
| 660 | 1 |
0.4%
|
|
| 800 | 2 |
0.9%
|
|
| 1000 | 37 |
16.4%
|
|
| 1200 | 1 |
0.4%
|
|
| 1451 | 1 |
0.4%
|
|
| 1700 | 1 |
0.4%
|
|
| 2000 | 2 |
0.9%
|
|
| 3000 | 1 |
0.4%
|
|
| 5000 | 1 |
0.4%
|
|
| Sysmiss | 7 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.